Coherus' cancer biosimilar faces supply squeeze after company's contract manufacturer overextends itself

17th September 2024 Uncategorised 0

Coherus’ cancer biosimilar faces supply squeeze after company’s contract manufacturer overextends itself
fkansteiner
Tue, 09/17/2024 – 14:03

More: Coherus' cancer biosimilar faces supply squeeze after company's contract manufacturer overextends itself
Source: fierce